Article Details

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Retrieved on: 2021-03-24 16:18:45

Tags for this article:

Click the tags to see associated articles and topics

NASH limits anti-tumour surveillance in immunotherapy-treated HCC. View article details on hiswai:

Excerpt

f, Quantification of CellCNN-analysed flow cytometry data for hepatic CD8+ T cells from mice fed for 12 months with CD-HFD and treated for 8 weeks ...

Article found on: www.nature.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up